Skip to main content

Table 3 Patients identified through newborn screening

From: The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients

Patient ID

Onset, diagnosis (Age)

ERT start (Age)

Biopsy site; time on ERT

Pathology/% fibers with lipofuscin inclusions Pretreatment

Pathology/% fibers with lipofuscin inclusions

Clinical status (Current age)

     

Follow-up

 

NBSL2

36 mo, ~12 d

3 y

Quad; baseline

Mild lysosomal expansion; autophagic accumulation and inclusions in ~85% of fibers

NA

Less endurance (5.9 y)

NBSL6

34 mo, ~9 d

2.8 y

Quad; 6 mo

NA

Normal biopsy

In preschool, no difficulties (5.2 y)

NBSL9*

1.5 mo, 14 d

1.5 mo

Quad; baseline & 6 mo

Autophagic accumulation in 12.5% of fibers; inclusions are in < 1% fibers

Mild lysosomal expansion in ~15% of fibers

Can jump on one foot (4.7 y)

NBSL15

2.8 mo, ~3 d

2.8 mo

Quad; baseline & 6 mo

**Inclusions in ~10% of fibers

Mild-to-moderate lysosomal expansion in 10% of fibers; autophagic accumulation in ~15% of fibers; many normal fibers

Runs quickly, can jump using two feet (2.5 y)

NBSL16

4.5 mo, ~3 d

4.5 mo

Quad; baseline & 7 mo

Mild-to-moderate lysosomal expansion; autophagic accumulation with inclusions in ~10% of fibers

Normal biopsy

Runs quickly; can jump using two feet (2.1 y)

  1. *Younger sibling of the juvenile-onset patient NBSL9a.
  2. **this specimen was not suitable for immunostaining; autofluorescent inclusions were detected in unstained fibers.